These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 4845080)

  • 41. Circadian rhythm-modulated chemotherapy with high dose 5-fluorouracil against gastrointestinal cancers: evaluation and case report.
    Kojima H; Sakamoto J; Yasue M
    Nagoya J Med Sci; 1999 May; 62(1-2):29-38. PubMed ID: 10504825
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [5-Fluorouracil in the treatment of gastrointestinal tumors].
    Aran M; Bilge N; Ozman M
    Turk Tip Dernegi Derg; 1973; 39(12):459-65. PubMed ID: 4377630
    [No Abstract]   [Full Text] [Related]  

  • 43. Chronotherapy with 5-fluorouracil and other drugs in gastrointestinal malignancies. Chronotherapy Group of the European Organization for Research and Treatment of Cancer.
    Misset JL; Lévi F
    Semin Oncol; 2000 Oct; 27(5 Suppl 10):78-82. PubMed ID: 11049036
    [No Abstract]   [Full Text] [Related]  

  • 44. [Immunochemotherapeutic treatment of gastrointestinal neoplasms].
    Bianucci P; Pastorino G
    Minerva Med; 1981 Nov; 72(46):3101-4. PubMed ID: 7301183
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Evaluation of tegafur encapsulated with slow-releasing granules (SF-SP) for patients with cancer of the digestive organs].
    Kameda C; Tanaka T; Shiomi M; Saka M; Katsu K; Itoh S
    Gan To Kagaku Ryoho; 1984 Dec; 11(12 Pt 1):2526-30. PubMed ID: 6439120
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Clinical use of 5-fluorouracil in surgical field].
    Suzuki T; Nishimura G; Imamura K; Sugahara K; Fujii Y
    Gan No Rinsho; 1969 May; 15(5):459-68. PubMed ID: 5387578
    [No Abstract]   [Full Text] [Related]  

  • 47. [Toxic effects of prolonged oral administration of tegafur (FT-207)].
    Majima H; Nishimura A
    Gan To Kagaku Ryoho; 1982 Apr; 9(4):726-32. PubMed ID: 7184423
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Clinical trial on the effect of tegafur (SF-SP)].
    Futatsuki K; Shimada S; Kanda Y; Ishibashi I; Sendai H; Akazawa S; Hattori M
    Gan To Kagaku Ryoho; 1984 May; 11(5):1112-5. PubMed ID: 6326685
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Double-blind, placebo-controlled, randomized study of chlorhexidine prophylaxis for 5-fluorouracil-based chemotherapy-induced oral mucositis with nonblinded randomized comparison to oral cooling (cryotherapy) in gastrointestinal malignancies.
    Sorensen JB; Skovsgaard T; Bork E; Damstrup L; Ingeberg S
    Cancer; 2008 Apr; 112(7):1600-6. PubMed ID: 18300265
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Systemic 5-fluorouracil for palliation of gastrointestinal cancer.
    Hart GD; Maxwell SB; Soots ML
    Appl Ther; 1968 Oct; 10(10):670-2. PubMed ID: 4177674
    [No Abstract]   [Full Text] [Related]  

  • 51. 5-Fluorouracil for gastrointestinal cancer.
    Ansfield FJ; Greenspan EM
    N Engl J Med; 1979 Aug; 301(6):328-9. PubMed ID: 450023
    [No Abstract]   [Full Text] [Related]  

  • 52. [Anticancer chemotherapy with evaluation of combined treatments].
    Saito T
    Poumon Coeur; 1968; 24(1):129-31. PubMed ID: 5652199
    [No Abstract]   [Full Text] [Related]  

  • 53. 5-fluorouracil increases the number and complexity of premature complexes in the heart: a prospective study using ambulatory ECG monitoring.
    Yilmaz U; Oztop I; Ciloglu A; Okan T; Tekin U; Yaren A; Somali I; Alacacioglu A; Kirimli O
    Int J Clin Pract; 2007 May; 61(5):795-801. PubMed ID: 17493091
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Phase II study of sequential methotrexate and 5-fluorouracil chemotherapy against peritoneally disseminated gastric cancer with malignant ascites: a report from the Gastrointestinal Oncology Study Group of the Japan Clinical Oncology Group, JCOG 9603 Trial.
    Yamao T; Shimada Y; Shirao K; Ohtsu A; Ikeda N; Hyodo I; Saito H; Iwase H; Tsuji Y; Tamura T; Yamamoto S; Yoshida S
    Jpn J Clin Oncol; 2004 Jun; 34(6):316-22. PubMed ID: 15333683
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Hepatic transcatheter arterial chemoembolization alternating with systemic protracted continuous infusion 5-fluorouracil for gastrointestinal malignancies metastatic to liver: a phase II trial of the Puget Sound Oncology Consortium (PSOC 1104).
    Bavisotto LM; Patel NH; Althaus SJ; Coldwell DM; Nghiem HV; Thompson T; Storer B; Thomas CR
    Clin Cancer Res; 1999 Jan; 5(1):95-109. PubMed ID: 9918207
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Toxicity and pharmacokinetics of a pyrrolizidine alkaloid, indicine N-oxide, in humans.
    Kovach JS; Ames MM; Powis G; Moertel CG; Hahn RG; Creagan ET
    Cancer Res; 1979 Nov; 39(11):4540-4. PubMed ID: 498086
    [No Abstract]   [Full Text] [Related]  

  • 57. Effects of 5-fluorouracil (NSC-19893) in 389 patients with cancer. Eastern Clinical Drug Evaluation Program.
    Moore GE; Bross ID; Ausmans R; Nadler S; Jones R; Slack N; Rimm AA
    Cancer Chemother Rep; 1968 Oct; 52(6):641-53. PubMed ID: 4895427
    [No Abstract]   [Full Text] [Related]  

  • 58. [Clinical studies on the use of selected cytostatics: 5-fluorouracil].
    Zelechowska JA
    Nowotwory; 1969; 19(2):105-10. PubMed ID: 5805803
    [No Abstract]   [Full Text] [Related]  

  • 59. [5 fluorouracil in local administration in cancerology].
    Cluzan R; Arnavon P; Le Blaye O; Lehn E; Lefesvre A; Levillain R
    Therapie; 1971; 26(6):1211-7. PubMed ID: 4111977
    [No Abstract]   [Full Text] [Related]  

  • 60. [Experiences and results in the treatment of ORL tumors with bleomycin and radiotherapy].
    Greiner R; Veraguth PC; Lampret T
    Strahlentherapie Sonderb; 1978; 75():149-57. PubMed ID: 95493
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.